Kalaris Therapeutics Inc
public_traded
Kalaris Therapeutics Inc is publicly traded on NASDAQ under ticker KLRS.
Kalaris Therapeutics Inc operates as a pharmaceutical company. The Company specializes in the development of novel cell therapies with a focus on restoring natural immunity against life-threatening virus-associated diseases in patients with severely weakened immune systems.